Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
Express Scripts
Colorcon
AstraZeneca
Merck

Last Updated: October 18, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR NIMBEX

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Nimbex

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01690338 A Study of Residual Curarization Incidence in China Unknown status Central South University Phase 4 2012-10-01 The purpose of this study is to determine the incidence of residual curarization in PACU and relevant risk factors.
NCT01690338 A Study of Residual Curarization Incidence in China Unknown status China Medical University Hospital Phase 4 2012-10-01 The purpose of this study is to determine the incidence of residual curarization in PACU and relevant risk factors.
NCT01690338 A Study of Residual Curarization Incidence in China Unknown status Chinese PLA General Hospital Phase 4 2012-10-01 The purpose of this study is to determine the incidence of residual curarization in PACU and relevant risk factors.
NCT01690338 A Study of Residual Curarization Incidence in China Unknown status Eastern Hepatobiliary Surgery Hospital Phase 4 2012-10-01 The purpose of this study is to determine the incidence of residual curarization in PACU and relevant risk factors.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Nimbex

Condition Name

Condition Name for Nimbex
Intervention Trials
Neuromuscular Blockade 3
Perioperative/Postoperative Complications 1
Ankle Fracture 1
Paralysis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Nimbex
Intervention Trials
Postoperative Complications 2
Respiratory Distress Syndrome, Newborn 2
Respiratory Distress Syndrome, Adult 2
Acute Lung Injury 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Nimbex

Trials by Country

Trials by Country for Nimbex
Location Trials
United States 18
China 11
Czech Republic 1
Lebanon 1
Thailand 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Nimbex
Location Trials
Massachusetts 1
Tennessee 1
Mississippi 1
New York 1
North Carolina 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Nimbex

Clinical Trial Phase

Clinical Trial Phase for Nimbex
Clinical Trial Phase Trials
Phase 4 4
Phase 3 1
Phase 2/Phase 3 1
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Nimbex
Clinical Trial Phase Trials
Recruiting 5
Completed 2
Unknown status 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Nimbex

Sponsor Name

Sponsor Name for Nimbex
Sponsor Trials
China Medical University Hospital 1
Zhujiang Hospital 1
Peking Union Medical College Hospital 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Nimbex
Sponsor Trials
Other 31
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Johnson and Johnson
Medtronic
Moodys
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.